Abnormal IGF-1/IGF-1R signaling has been extensively studied in lung cancer that mediates oncogenesis, progression, metastasis, resistance to chemotherapy, or tyrosine kinase inhibitors (TKIs) [6]. Here, IGF1 is linked to lung carcinoma.